Altogether, our data show that β-cell-specific ablation of LATS2 diminished progressive hyperglycemia and improved glucose tolerance, insulin secretion, and β-cell mass in the MLD-STZ mouse model of β-cell destruction and diabetes. This evidence concerns the gene INS and diabetes mellitus.